Skip to main content
Home
Division of Cancer Prevention
Making cancer prevention possible
  • Home
  • Major Programs
    • Major Programs
    • Cancer Immunoprevention Network (CIP-Net)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention Fellowship Program (CPFP)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
    • Early Detection Research Network (EDRN)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • NCI Community Oncology Research Program (NCORP)
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Pre-Cancer Atlas (PCA)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials
    • Clinical Trials Search
    • Clinical Trials Management
  • Funding & Grants
    • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
    • Workforce Initiatives
  • Resources
    • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System (CDAS)
    • NCI Resources for Cancer Immunoprevention Research
  • News & Events
    • News & Events
    • News
    • Blog
    • DCP Updates
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • About DCP
    • Scientific Scope
    • DCP Leadership
    • History and Timeline
    • Staff Directory
  1. Home
  2. Major Programs
  • Cancer Screening Research Network (CSRN)
    • Purpose and Structure of the Network
    • Vanguard Study
    • Questions and Answers About the CSRN
    • Grantee Details
    • Questions and Answers about Multi-Cancer Detection Tests
    • NCI Publications and Presentations
    • Workshop to Engage Multi-Cancer Detection Assay Developers

Contact CSRN

Email: CSRN@nih.gov

The Fred Hutchinson Cancer Center leads the CSRN multi-center effort to examine the effectiveness of emerging technologies for cancer screening.

Badge of the Cancer Screening Research Network

Look for this badge at participating Program organizations and institutions. It means they have been awarded a grant by the National Cancer Institute (NCI) as a member of the Cancer Screening Research Network (CSRN).

Cancer Screening Research Network (CSRN)

Group photo of the Cancer Screening Research Network (CSRN)

The Network

Purpose and Structure Questions and Answers about the Network Grantee Information

The Vanguard Study

Vanguard Study Information Multi-Cancer Detection Tests: Questions and Answers NCI Scientific Publications about MCD Technology May 2023 Workshop to Engage Multi-Cancer Detection Assay Developers

Latest News and Initiatives

An illustration of a test tube filled with blood next to a clipboard.

NCI Selects Two Assays for the Vanguard Study on Multi-Cancer Detection Tests

NCI Virtual Workshop to Engage Multi-Cancer Detection Assay Developers

NCI Virtual Workshop to Engage Multi-Cancer Detection Assay Developers

A gloved hand holding a test tube filled with blood with depictions of DNA, RNA, mutations, and cells..

Questions and Answers about Multi-Cancer Detection Tests

FOLLOW US AT:

The National Cancer Institute

NCI Division of Cancer Prevention

POLICIES

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI'S PDQ® EVIDENCE-BASED SUMMARIES

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

GENERAL INFORMATION

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®